Table 2.

Fatty acid composition of phospholipids in visceral adipose tissue from non-obese patients and morbid obese patients.

Fatty Acid		Non-Obese	MO-Low-IR	MO-High-IR	MO-Metf-TDM2
Lauric acid	12:0	0.58 ± 0.48	0.11 ± 0.17	0.25 ± 0.38	0.26 ± 0.24
Myristic acid	14:0	1.44 ± 0.29	2.18 ± 1.78	1.28 ± 0.92	1.40 ± 1.10
Palmitic acid	16:0	22.772.8	22.2 ± 1.9	22.9 ± 3.1	21.7 ± 1.5
Palmitoleic acid	16:1n-7	2.63 ± 0.81	2.92 ± 1.07	3.01 ± 0.82	2.41 ± 0.49
Stearic acid	18:0	15.8 ± 3.9	12.2 ± 2.0 a	12.8 ± 2.2	12.8 ± 1.2
Oleic acid	18:1n-9	30.4 ± 4.8	28.2 ± 3.5	27.9 ± 4.6	26.5 ± 5.5
Vaccenic acid	18:1n-7	0.94 ± 1.33	2.62 ± 0.55 a	2.35 ± 1.38 a	2.10 ± 1.04
Linoleic acid	18:2n-6	16.1 ± 4.5	17.8 ± 2.0	14.7 ± 3.5	16.4 ± 3.0
Gamma-linolenic acid	18:3n-6	0.03 ± 0.08	0.02 ± 0.06	0.07 ± 0.27	0.01 ± 0.01
α-Linoleic acid	18:3n-3	0.29 ± 0.32	0.54 ± 0.84	0.28 ± 0.38	0.55 ± 0.54
Eicosanoic acid	20:0	1.01 ± 0.50	0.54 ± 0.54	1.09 ± 1.06	1.29 ± 0.51
Gondoic acid	20:1n-9	0.80 ± 0.61	0.89 ± 0.34	1.12 ± 1.79	1.13 ± 0.58
Eicosadienoic acid	20:2n-6	0.47 ± 0.51	0.73 ± 0.59	0.62 ± 1.06	0.87 ± 0.60
Dihomo-gamma-linolenic acid	20:3n-6	0.73 ± 0.34	1.17 ± 0.57	1.32 ± 1.33	1.79 ± 0.86
Arachidonic acid	20:4n-6	4.18 ± 1.48	5.62 ± 1.39	6.33 ± 1.99 a	7.24 ± 2.28 a
Eicosatrienoic acid	20:3n-3	0.05 ± 0.09	0.14 ± 0.28	0.33 ± 0.24	0.18 ± 0.20
Eicosapentaenoic acid	20:5n-3	0.35 ± 0.29	0.27 ± 0.32	0.50 ± 0.63	1.04 ± 1.49
Adrenic acid	22:4n-6	0.37 ± 0.35	0.72 ± 0.55	1.01 ± 1.03	0.68 ± 0.47
Docosapentaenoic acid	22:5n-3	0.24 ± 0.27	0.23 ± 0.35	0.65 ± 0.86	0.49 ± 0.48
Docosahexaenoic acid	22:6n-3	0.61 ± 0.98	0.80 ± 0.64	0.77 ± 1.01	1.08 ± 0.74
Total saturated fatty acids		41.6 ± 5.9	37.2 ± 3.7	38.9 ± 5.0	37.4 ± 2.3
Total monounsaturated fatty acids		34.7 ± 4.8	34.6 ± 4.0	34.4 ± 5.1	32.2 ± 5.5
n-3 polyunsaturated fatty acids		1.54 ± 1.45	1.99 ± 1.28	2.54 ± 2.34	3.35 ± 3.11
n-6 polyunsaturated fatty acids		22.0 ± 5.1	26.0 ± 2.1	24.1 ± 4.9	26.9 ± 3.7

Results are represented as mean ± SD. ^a p < 0.05 significant differences with regard to the non-obese patients.